Research Overview

KPV is a tripeptide derived from the C-terminal sequence of α-MSH and is widely used in laboratory settings as a tool compound for investigating melanocortin-related anti-inflammatory signaling, epithelial barrier integrity and cellular stress responses in skin and intestinal research models. No therapeutic or clinical claims are made or implied.

Primary Research Areas

• Anti-inflammatory pathways: experimental models investigating suppression of pro-inflammatory signaling and modulation of cytokine and chemokine responses.
• Intestinal barrier and epithelial integrity: research focused on tight-junction proteins, epithelial repair dynamics, barrier function and responses under inflammatory challenge.
• Skin and keratinocyte models: experimental systems exploring oxidative stress, inflammatory pathways, keratinocyte behaviour and melanocortin-related effects in skin cells.
• Melanocortin and α-MSH signaling: studies in which KPV serves as the minimal α-MSH fragment to probe receptor-mediated anti-inflammatory and protective signaling mechanisms.

Reconstitution

The lyophilized powder is typically reconstituted with a sterile research solvent such as bacteriostatic water (BAC), which supports handling stability and reduces the risk of contamination.